Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hallucinogens”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06943573
What this trial is testing

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Who this might be right for
Bipolar II Depression
Lakshmi N Yatham 90
Early research (Phase 1)Looking for participantsNCT06772753
What this trial is testing

Investigation of Psychedelic Effects in Psychoactive Substances

Who this might be right for
Psychedelic Effects in Healthy Volunteers
Johns Hopkins University 50
Testing effectiveness (Phase 2)Study completedNCT02914769
What this trial is testing

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

Who this might be right for
Major Depression
Universidade Federal do Rio Grande do Norte 35
Not applicableStudy completedNCT06650800
What this trial is testing

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, Treatment-ResistantHallucinogens+1 more
Centre Hospitalier Universitaire de Nīmes 10
Not applicableLooking for participantsNCT06368492
What this trial is testing

The Impact of Psilocybin on Pain in Fibromyalgia Patients

Who this might be right for
Fibromyalgia
Maastricht University 35
Not applicableNot Yet RecruitingNCT07824973
What this trial is testing

Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing

Who this might be right for
Treatment Resistant Depression (TRD)
Valdemar Landgren 120
Early research (Phase 1)Ended earlyNCT05322954
What this trial is testing

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

Who this might be right for
Methamphetamine Use DisorderSubstance-Related DisordersChemically-Induced Disorders+2 more
University of Wisconsin, Madison 5
Very early researchActive Not RecruitingNCT05953038
What this trial is testing

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

Who this might be right for
Basic Science
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756736
What this trial is testing

Psilocybin Therapy for Methamphetamine Use Disorder and HIV

Who this might be right for
Methamphetamine Use DisorderHuman Immunodeficiency Virus (HIV)
Nicky Mehtani, MD, MPH 30
Not applicableLooking for participantsNCT07309471
What this trial is testing

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Who this might be right for
LSD Reaction
University Hospital, Basel, Switzerland 24
Early research (Phase 1)Active Not RecruitingNCT06506019
What this trial is testing

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression

Who this might be right for
Bipolar Depression
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT03429075
What this trial is testing

Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms

Who this might be right for
Depressive Disorder, Major
Imperial College London 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07791901
What this trial is testing

MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial

Who this might be right for
Advanced CancerDemoralizationExistential Distress+1 more
University of Calgary 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06303739
What this trial is testing

Psilocybin-Assisted Therapy in Treatment-Resistant Depression

Who this might be right for
Refractory DepressionTreatment Resistant Depression
University of North Carolina, Chapel Hill 20
Not applicableStudy completedNCT06581263
What this trial is testing

Psychedelic Virtual Reality

Who this might be right for
Psychedelic ExperiencesVirtual RealityHealthy Volunteer
Yale University 10
Not applicableStudy completedNCT06235411
What this trial is testing

Psilocybin in Alcohol Use Disorder With Comorbid Depression

Who this might be right for
Alcohol-Related DisordersDepressive DisorderAddiction
Centre Hospitalier Universitaire de Nīmes 30
Early research (Phase 1)Study completedNCT05175430
What this trial is testing

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 24
Early research (Phase 1)Study completedNCT05224336
What this trial is testing

Psilocybin-assisted Therapy for Phantom Limb Pain

Who this might be right for
Phantom Limb Pain
University of California, San Diego 10
Not applicableStudy completedNCT05895318
What this trial is testing

Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

Who this might be right for
Post Traumatic Stress Disorder
Albany Research Institute, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06768944
What this trial is testing

Subjective Experience Following Psilocybin

Who this might be right for
Investigating the Importance of the Subjective Psychedelic Experience
University of Calgary 128
Next Page